Cromwell Holdings’s Quest Diagnostics DGX Stock Holding History

Cromwell Holdings’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.4K	Buy	389 +17	+5%	+$3.34K	0.04%	399
2026 Q1	$72.9K	Hold	372	–	–	0.04%	394
2025 Q4	$64.6K	Hold	372	–	–	0.04%	419
2025 Q3	$70.9K	Buy	372 +4	+1%	+$710	0.04%	402
2025 Q2	$66.1K	Buy	368 +13	+4%	+$2.26K	0.04%	398
2025 Q1	$60.1K	Buy	355 +6	+2%	+$986	0.04%	410
2024 Q4	$52.6K	Hold	349	–	–	0.03%	438
2024 Q3	$54.2K	Buy	349 +38	+12%	+$5.67K	0.03%	429
2024 Q2	$42.6K	Buy	+311	New	+$42.6K	0.03%	467

Other funds holding DGX

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

JWM

JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GIA

GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

Cromwell Holdings's DGX Position: Q2 2026 in Review

Cromwell Holdings increased its Quest Diagnostics (DGX) stake by 4.6% in Q2 2026, buying an estimated $3.34K and bringing the position to 389 shares worth $82.4K. The position accounts for 0.04% of the portfolio, ranked #399.

Cromwell Holdings first reported a position in DGX in Q2 2024 and has held it in 9 quarters since. 210 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Cromwell Holdings held 389 shares of Quest Diagnostics worth $82.4K as of Q2 2026.
Cromwell Holdings bought 17 Quest Diagnostics shares in Q2 2026, an estimated $3.34K.
Quest Diagnostics made up 0.04% of Cromwell Holdings's portfolio in Q2 2026, its #399 holding.
Cromwell Holdings first reported a position in Quest Diagnostics in Q2 2024 and has held it in 9 quarters since.
210 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.